FRENCH FOOD SAFETY AUTHORITY CAUTIONS THE USE OF ARTHRITIS SUPPLEMENTS
France
May 04, 2019
A recent report advises against the consumption of food supplements containing glutamine and/or chondroitin sulfate for certain population groups. The undesired adverse effects can include digestive problems, abdominal pain, rash, itching, hepatitis or haemorrhagic lesions of the skin. At present, food supplements and medicinal products containing glucosamine and chondroitin sulfate are widely available.
Although the French Food Safety Authority, named ANSES, also recognises in its report that both glucosamine and chondroitin sulfate contain compounds naturally found in the connecting tissues and cartilage of our the human body which promote the structure and elasticity of cartilage tendons and skin. For certain risk groups the consumption of both substances should be avoided. The identified risk groups are:
(i) people with diabetes or pre-diabetic, asthmatic or treated with anti-vitamin K,
(ii) (for food supplements based on glucosamine) people with a food allergy to crustaceans or insects.
(iii) people whose diet is controlled for sodium, potassium or calcium, as these supplements can be an important source.
(iv) children and pregnant or breastfeeding women.
ANSES advises food producers to take account of the risk groups and appropriately inform consumers. In addition, it calls for the establishment of harmonised European Union maximum use levels for both glucosamine and chondroitin sulfate.
ANSES (29/03/2019) - Les compléments alimentaires à visée articulaire déconseillés à certaines populations - link
Phosphatidylserine (soy) authorized for use as a supplementary ingredient in foodstuffs
Canada
Apr 18, 2024
Nigeria/USA - Navigating regulatory challenges and safety considerations in lactation supplement development: A Nigeria and US Comparison
Nigeria
Apr 17, 2024
FDA proposed to revise the standards for registration criteria and procedures for Health Supplements
Indonesia
Apr 17, 2024
CRN new guidelines for melatonin supplements and labeling of gummy supplements
USA
Apr 15, 2024
Guidelines on soy-derived phosphatidylserine food ingredients
Israel
Apr 15, 2024
New rules for dietary supplements handling companies in Michigan
USA
Apr 12, 2024
FDA warns about toxic yellow oleander in dietary supplements
USA
Apr 11, 2024
Algae list added to Germany's substances list
European Union
Apr 11, 2024
FDA Draft Guidance on New Dietary Ingredient Notification Master Files for Dietary Supplements
USA
Apr 08, 2024
ANVISA updates regulation on food supplements
Brazil
Mar 08, 2024
TGA updates list of permissible ingredients in Therapeutic Goods
Australia
Mar 08, 2024
FDA new guidance on "New Dietary Ingredient Notification Procedures and Timeframes"
USA
Mar 03, 2024
ANVISA revises pre-market control system
Brazil
Feb 28, 2024
FDA updates directory of ingredients used in dietary supplements
USA
Feb 21, 2024
USA - A Review of Probiotic Ingredient Safety Supporting Monograph Development Conducted by the United States Pharmacopeia (USP)
USA
Feb 19, 2024
